title: Herault breast screening programme: results after 30 months of a mobile French schedule.
abstract: Breast screening in the Herault Department (France) has been carried out since July 1990. As with other French programmes, it is a population-based screen, whose main features are related to its organization in that: (a) it is performed by a specific unit (the 'Institut Montpelliérain d'Imagerie Medico-Biologique'); and (b) the group of women targeted is those aged 40-70 years. The two-view mammography is performed every 2 years in mobile units. This paper presents the results after 30 months: 26,026 participants were screened from a target population of 52,617 women, giving a participation rate of 49%. The recall rate and the biopsy rate observed were 7% and 1.5%, respectively. The predictive positive value was 8.4% for a positive test while it was 35% for the biopsy; the values increased with age. 137 cancers were observed giving a detection rate of 5.3%, of which 82% were in situ. Small (< or = to 10 mm) tumours represented 41.5%, and 71.5% of the cancers were node negative. The surgical treatment was conservative for 66% of them.
authors.affiliation: Départment de Santé Publique, Epidémiologie, Biostatistiques et Informatique Módicale, Centre Hospitalier Régional de Nîmes, France.
authors.forename: F
authors.initials: F
authors.lastname: Séguret
authors.forename: J P
authors.initials: JP
authors.lastname: Daures
authors.forename: A V
authors.initials: AV
authors.lastname: Guizard
authors.forename: H
authors.initials: H
authors.lastname: Mathieu-Daude
authors.forename: J C
authors.initials: JC
authors.lastname: Bonifacj
authors.forename: J
authors.initials: J
authors.lastname: Cherifcheik
authors.forename: J L
authors.initials: JL
authors.lastname: Lamarque
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D001071:Appointments and Schedules; D001706:Biopsy; D001943:Breast Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology / Q000517:prevention & control* / Q000601:surgery; D002278:Carcinoma in Situ / Q000000981:diagnostic imaging / Q000473:pathology / Q000517:prevention & control / Q000601:surgery; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D005602:France; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology; D008327:Mammography; D008403:Mass Screening / Q000379:methods*; D008875:Middle Aged; D008952:Mobile Health Units; D009367:Neoplasm Staging; D011159:Population Surveillance; D011237:Predictive Value of Tests; D012423:Rural Health; D014504:Urban Health